Treatment of Severe Ocular Mpox with Cidofovir and Tecovirimat
Mpox, a reemerging zoonotic disease since 2022, primarily affects the skin; ocular involvement is rarely reported. We present a case of mpox-caused disciform keratitis treated with a combination of cidofovir and tecovirimat. The patient recovered without residual ocular sequelae, suggesting these drugs are an option to treat ocular mpox manifestations.
Authors
- Marin Lahouati (ORCID: https://orcid.org/0000-0003-0043-7336)
- Eugénie Mourgues
- Valentine Saunier (ORCID: https://orcid.org/0000-0003-1293-4831)
- Charles Cazanave (ORCID: https://orcid.org/0000-0002-4613-3963)
- Sonia Burrel (ORCID: https://orcid.org/0000-0002-7783-2601)
- Rayan Kreidie
- Vincent Servant
- Xavier Brousse
- Luna Fraysse
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3201/eid3204.250882
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.00